Ledger.Open graph →
SEC Form D · filed September 15, 2009

Pervasis Therapeutics Inc

Offering
$17.4M
Sold
$10.0M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (12)

Amir Nashat · Cambridge, MADirectorFrederic Chereau · Cambridge, MAExec · DirectorHelen M. Nugent · Cambridge, MAExecEarl M. Collier · Cambridge, MADirectorElazer R. Edelman · Cambridge, MADirectorRobert F. Higgins · Cambridge, MADirectorPeter B. Hutt · Cambridge, MADirectorEdwin M. Kania · Cambridge, MADirectorRobert S. Langer · Cambridge, MADirectorFrank Litvack · Cambridge, MADirectorAmir Nashat · San Diego, CADirectorYoram Richter · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗